Growth Hormone Deficiency Market Size, Share and Forecast 2026
The Growth Hormone Deficiency Market was worth $XX million in 2018 and is forecasted to reach $XX million by 2026, at a CAGR of XX% during the forecast period.
(EMAILWIRE.COM, September 13, 2019 ) Market Overview:
Growth hormone deficiency (GHD) is a rare endocrine disorder that occurs due to impaired secretion of somatropin, a peptide growth hormone (GH) from the pituitary gland which is responsible for the growth and cell reproduction. GHD is classified into three categories: congenital, acquired, or idiopathic. Congenital GHD is present at the time of birth and can be caused either by genetic mutations or structural abnormality in the brain.
Market Dynamics:
The market is driven by an increase in the incidences of GHD, the introduction of technologically advanced drugs with improved patient compliance and increased awareness of the disease. The high cost of treatment for GHD is the only reason that is expected to restrain the market growth over the period of forecast.
Market Segmentation:
By Treatment
• Surgery
• Growth Hormone Therapy
By End User
• Hospitals
• Clinics
• Home Care Setting
By Distribution Channel
• Hospital pharmacies
• Retail pharmacies
• Online pharmacies
Geographical Analysis:
By Geography, the market is segmented into:
• North America
• Europe
• South America
• Asia Pacific
• The Middle East and Africa
Competitive Analysis:
Key Players:
• Sandoz International GmbH*
• Sanofi-Aventis
• Pfizer
• Novo Nordisk A/S
• Teva Pharmaceutical Industries Limited
• Ranbaxy
• Others
View full report: https://www.datamintelligence.com/research-report/growth-hormone-deficiency-market
Download free sample:
About Us:
DataM Intelligence was incorporated in the early weeks of 2017 as a Market Research and Consulting firm with just two people on board. Within a span of less than a year we have secured more than 100 unique customers from established organizations all over the world.
For more information:
Sai Kiran
Sales Manager at Data M Intelligence
Email: info@datamintelligence.com
Tel: +1 877 441 4866
Website: www.datamintelligence.com
Growth hormone deficiency (GHD) is a rare endocrine disorder that occurs due to impaired secretion of somatropin, a peptide growth hormone (GH) from the pituitary gland which is responsible for the growth and cell reproduction. GHD is classified into three categories: congenital, acquired, or idiopathic. Congenital GHD is present at the time of birth and can be caused either by genetic mutations or structural abnormality in the brain.
Market Dynamics:
The market is driven by an increase in the incidences of GHD, the introduction of technologically advanced drugs with improved patient compliance and increased awareness of the disease. The high cost of treatment for GHD is the only reason that is expected to restrain the market growth over the period of forecast.
Market Segmentation:
By Treatment
• Surgery
• Growth Hormone Therapy
By End User
• Hospitals
• Clinics
• Home Care Setting
By Distribution Channel
• Hospital pharmacies
• Retail pharmacies
• Online pharmacies
Geographical Analysis:
By Geography, the market is segmented into:
• North America
• Europe
• South America
• Asia Pacific
• The Middle East and Africa
Competitive Analysis:
Key Players:
• Sandoz International GmbH*
• Sanofi-Aventis
• Pfizer
• Novo Nordisk A/S
• Teva Pharmaceutical Industries Limited
• Ranbaxy
• Others
View full report: https://www.datamintelligence.com/research-report/growth-hormone-deficiency-market
Download free sample:
About Us:
DataM Intelligence was incorporated in the early weeks of 2017 as a Market Research and Consulting firm with just two people on board. Within a span of less than a year we have secured more than 100 unique customers from established organizations all over the world.
For more information:
Sai Kiran
Sales Manager at Data M Intelligence
Email: info@datamintelligence.com
Tel: +1 877 441 4866
Website: www.datamintelligence.com
Contact Information:
DataM Intelligence
Sai Kiran
Tel: +1 877 441 4866
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results
DataM Intelligence
Sai Kiran
Tel: +1 877 441 4866
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results